We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-9.35%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.04B
AUM Growth
-$609M
Cap. Flow
-$33.8M
Cap. Flow %
-0.67%
Top 10 Hldgs %
35.06%
Holding
103
New
3
Increased
32
Reduced
49
Closed
2

Top Buys

Rank Stock Value
1
CIXX
CI Financial Corp.
CIXX
+$24.3M
2
GSK icon
GSK
GSK
+$20.6M
3
CAE icon
CAE Inc
CAE
+$18.9M
4
HBM icon
Hudbay
HBM
+$11.4M
5
THC icon
Tenet Healthcare
THC
+$9.86M

Top Sells

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$46.9M
2
CVE icon
Cenovus Energy
CVE
+$26.1M
3
CNQ icon
Canadian Natural Resources
CNQ
+$20.5M
4
SU icon
Suncor Energy
SU
+$20M
5
BHC icon
Bausch Health
BHC
+$13.8M

Sector Composition

Rank Sector Weight
1 Financials 30.39%
2 Communication Services 16.64%
3 Energy 12.07%
4 Materials 11.86%
5 Healthcare 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLR icon
76
Fluor
FLR
$7.23B
$6.73M 0.13%
270,520
-8,200
-3% -$209K
WBD icon
77
Warner Bros
WBD
$70.3B
$6.54M 0.13%
568,237
-198,277
-26% -$2.69M
PROF
78
Profound Medical
PROF
$208M
$5.01M 0.1%
1,255,675
+650
+0.1% +$4.39K
YTRA icon
79
Yatra Online
YTRA
$64.6M
$4.88M 0.1%
2,188,020
+50,000
+2% +$129K
PDS
80
Precision Drilling
PDS
$1.15B
$3.48M 0.07%
68,340
-31,000
-31% -$1.88M
SCHW
81
Charles Schwab
SCHW
$186B
$1.57M 0.03%
21,846
– –
MYOV
82
DELISTED
Myovant Sciences Ltd.
MYOV
$1.14M 0.02%
63,204
– –
VT icon
83
Vanguard Total World Stock ETF
VT
$80.6B
$972K 0.02%
12,325
– –
MET icon
84
MetLife
MET
$62.4B
$796K 0.02%
13,099
– –
ING icon
85
ING
ING
$105B
$776K 0.02%
91,250
-986
-1% -$9.14K
ENB icon
86
Enbridge
ENB
$106B
$397K 0.01%
10,650
– –
REPL icon
87
Replimune Group
REPL
$1.23B
$394K 0.01%
22,800
– –
OM icon
88
Outset Medical
OM
$59M
$358K 0.01%
1,500
– –
DUK icon
89
Duke Energy
DUK
$91.8B
$288K 0.01%
3,100
– –
FTS icon
90
Fortis
FTS
$27.3B
$282K 0.01%
7,375
– –
GOOGL icon
91
Alphabet (Google) Class A
GOOGL
$4.22T
$264K 0.01%
+2,760
New +$306K
HRTX icon
92
Heron Therapeutics
HRTX
$59.6M
$241K ﹤0.01%
57,200
– –
NUE icon
93
Nucor
NUE
$58.7B
$230K ﹤0.01%
2,150
-750
-26% -$94.1K
KMB icon
94
Kimberly-Clark
KMB
$32.8B
$228K ﹤0.01%
2,025
– –
SPRO icon
95
Spero Therapeutics
SPRO
$65.8M
$147K ﹤0.01%
73,659
– –
CVE.WS
96
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$129K ﹤0.01%
15,254
+58
+0.4% +$741
IMV
97
DELISTED
IMV Inc. Common Shares
IMV
$88K ﹤0.01%
17,000
– –
MDNA
98
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$83K ﹤0.01%
100,000
– –
ATRA icon
99
Atara Biotherapeutics
ATRA
$94.8M
$59K ﹤0.01%
628
– –
ONCR
100
DELISTED
Oncorus, Inc.
ONCR
$50K ﹤0.01%
59,150
– –
1 2 3
4
5

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Letko, Brosseau & Associates held 103 positions worth $5.04B, down 11% from $5.65B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.9%. Letko, Brosseau & Associates opened 3 new positions and exited 2, leaving the 103-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

  • Letko, Brosseau & Associates's largest Q3 2022 buy was CI Financial Corp.: 2,192,000 shares worth $21.1M.
  • Letko, Brosseau & Associates added most to CAE Inc in Q3 2022, an estimated $18.9M increase.
  • Letko, Brosseau & Associates's biggest Q3 2022 reduction was Cenovus Energy, cutting an estimated $26.1M.
  • Letko, Brosseau & Associates fully exited Adient in Q3 2022, selling an estimated $46.9M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $5.04B portfolio in Q3 2022.
  • Letko, Brosseau & Associates opened 3 new positions and closed 2 in Q3 2022.
  • Letko, Brosseau & Associates's portfolio value fell 11% quarter-over-quarter to $5.04B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2022, filed 10 Nov 2022.